Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study

REFERENCES

1. 1.↵
   2. Kidd D,
   3. Barkhof F,
   4. McConnell R, et al

   . Cortical lesions in multiple sclerosis. Brain 1999;122(pt 1):17–26 doi:10.1093/brain/122.1.17 pmid:10050891

   Abstract/FREE Full Text
2. 2.↵
   2. Peterson JW,
   3. Bö L,
   4. Mörk S, et al

   . Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400 doi:10.1002/ana.1123 pmid:11558796

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Geurts JJ,
   3. Blezer EL,
   4. Vrenken H, et al

   . Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol 2008;255:183–91 doi:10.1007/s00415-008-0620-5 pmid:18231704

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Filippi M,
   3. Rocca MA,
   4. Calabrese M, et al

   . Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010;75:1988–94 doi:10.1212/WNL.0b013e3181ff96f6 pmid:21115953

   Abstract/FREE Full Text
5. 5.↵
   2. Roosendaal SD,
   3. Moraal B,
   4. Pouwels PJ, et al

   . Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009;15:708–14 doi:10.1177/1352458509102907 pmid:19435749

   Abstract/FREE Full Text
6. 6.↵
   2. Nelson F,
   3. Datta S,
   4. Garcia N, et al

   . Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler 2011;17:1122–29 doi:10.1177/1352458511405561 pmid:21543552

   Abstract/FREE Full Text
7. 7.↵
   2. Vaughan JT,
   3. Garwood M,
   4. Collins CM, et al

   . 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 2001;46:24–30 doi:10.1002/mrm.1156 pmid:11443707

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Metcalf M,
   3. Xu D,
   4. Okuda DT, et al

   . High-resolution phased-array MRI of the human brain at 7 Tesla: initial experience in multiple sclerosis patients. J Neuroimaging 2010;20:141–47 doi:10.1111/j.1552-6569.2008.00338.x pmid:19187478

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Tallantyre EC,
   3. Morgan PS,
   4. Dixon JE, et al

   . 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 2010;32:971–77 doi:10.1002/jmri.22115 pmid:20882628

   CrossRefPubMed
10. 10.↵
    2. Nielsen AS,
    3. Kinkel RP,
    4. Tinelli E, et al

    . Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging 2012;35:537–42 doi:10.1002/jmri.22847 pmid:22045554

    CrossRefPubMed
11. 11.↵
    2. Kollia K,
    3. Maderwald S,
    4. Putzki N, et al

    . First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30:699–702 doi:10.3174/ajnr.A1434 pmid:19147714

    Abstract/FREE Full Text
12. 12.↵
    2. Yao B,
    3. Bagnato F,
    4. Matsuura E, et al

    . Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012;262:206–15 doi:10.1148/radiol.11110601 pmid:22084205

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Pitt D,
    3. Boster A,
    4. Pei W, et al

    . Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010;67:812–18 doi:10.1001/archneurol.2010.148 pmid:20625086

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Bø L,
    3. Vedeler CA,
    4. Nyland HI, et al

    . Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723–32 pmid:12901699

    PubMedWeb of Science
15. 15.↵
    2. Bagnato F,
    3. Hametner S,
    4. Welch EB

    . Visualizing iron in multiple sclerosis. Magn Reson Imaging 2013;31:376–84 doi:10.1016/j.mri.2012.11.011 pmid:23347601

    CrossRefPubMed
16. 16.↵
    2. Geurts JJ,
    3. Bö L,
    4. Pouwels PJ, et al

    . Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572–77 pmid:15760868

    Abstract/FREE Full Text
17. 17.↵
    2. Seewann A,
    3. Kooi EJ,
    4. Roosendaal SD, et al

    . Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012;78:302–08 doi:10.1212/WNL.0b013e31824528a0 pmid:22218278

    Abstract/FREE Full Text
18. 18.↵
    2. Geurts JJ,
    3. Pouwels PJ,
    4. Uitdehaag BM, et al

    . Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254–60 doi:10.1148/radiol.2361040450 pmid:15987979

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Yao B,
    3. Hametner S,
    4. van Gelderen P, et al

    . 7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PLoS One 2014;9:e108863 doi:10.1371/journal.pone.0108863 pmid:25303286

    CrossRefPubMed
20. 20.↵
    2. Seewann A,
    3. Vrenken H,
    4. Kooi EJ, et al

    . Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011;17:1202–10 doi:10.1177/1352458511406575 pmid:21561955

    Abstract/FREE Full Text
21. 21.↵
    2. Samson RS,
    3. Cardoso MJ,
    4. Muhlert N, et al

    . Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups. Mult Scler 2014;20:1322–30 doi:10.1177/1352458514522537 pmid:24552746

    Abstract/FREE Full Text
22. 22.↵
    2. Bö L,
    3. Geurts JJ,
    4. Ravid R, et al

    . Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathol Appl Neurobiol 2004;30:106–17 doi:10.1111/j.1365-2990.2003.00521.x pmid:15043708

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Vercellino M,
    3. Plano F,
    4. Votta B, et al

    . Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101–07 doi:10.1097/01.jnen.0000190067.20935.42 pmid:16319720

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Pfefferbaum A,
    3. Sullivan EV,
    4. Adalsteinsson E, et al

    . Postmortem MR imaging of formalin-fixed human brain. Neuroimage 2004;21:1585–95 doi:10.1016/j.neuroimage.2003.11.024 pmid:15050582

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Simon B,
    3. Schmidt S,
    4. Lukas C, et al

    . Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 2010;20:1675–83 doi:10.1007/s00330-009-1705-y pmid:20094887

    CrossRefPubMedWeb of Science
26. 26.↵
    2. de Graaf WL,
    3. Kilsdonk ID,
    4. Lopez-Soriano A, et al

    . Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol 2013;23:528–40 doi:10.1007/s00330-012-2619-7 pmid:22898935

    CrossRefPubMed
27. 27.↵
    2. Nielsen AS,
    3. Kinkel RP,
    4. Madigan N, et al

    . Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 2013;81:641–49 doi:10.1212/WNL.0b013e3182a08ce8 pmid:23864311

    Abstract/FREE Full Text
28. 28.↵
    2. Kilsdonk ID,
    3. de Graaf WL,
    4. Soriano AL, et al

    . Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR. AJNR Am J Neuroradiol 2013;34:791–96 doi:10.3174/ajnr.A3289 pmid:23042930

    Abstract/FREE Full Text
29. 29.↵
    2. Sethi V,
    3. Yousry TA,
    4. Muhlert N, et al

    . Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012;83:877–82 doi:10.1136/jnnp-2012-303023 pmid:22807559

    Abstract/FREE Full Text